Todd M. Suter

1.1k total citations · 1 hit paper
12 papers, 740 citations indexed

About

Todd M. Suter is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Todd M. Suter has authored 12 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 4 papers in Endocrine and Autonomic Systems. Recurrent topics in Todd M. Suter's work include Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (6 papers) and Regulation of Appetite and Obesity (4 papers). Todd M. Suter is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (6 papers) and Regulation of Appetite and Obesity (4 papers). Todd M. Suter collaborates with scholars based in United States, United Kingdom and Denmark. Todd M. Suter's co-authors include Michael A. Statnick, Mark L. Heiman, Matthias H. Tschöp, Paul J. Emmerson, M Gabe, David B. Wainscott, Jonathan E. Campbell, David A. D’Alessio, Francis S. Willard and Mette M. Rosenkilde and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Endocrinology.

In The Last Decade

Todd M. Suter

11 papers receiving 717 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

2020 314 citations Francis S. Willard, Jonathan D. Douros et al. JCI Insight profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd M. Suter United States	9	283	270	258	242	187	12	740
Jennifer Athanacio United States	9	192 0.7×	219 0.8×	130 0.5×	200 0.8×	222 1.2×	9	554
Edwin T. Parlevliet Netherlands	14	286 1.0×	330 1.2×	185 0.7×	181 0.7×	194 1.0×	15	776
Peter S. Griffin United States	6	157 0.6×	243 0.9×	185 0.7×	168 0.7×	230 1.2×	6	572
R. Troke United Kingdom	7	222 0.8×	361 1.3×	176 0.7×	195 0.8×	61 0.3×	8	669
Elizabeth Zieliński United States	7	287 1.0×	127 0.5×	175 0.7×	173 0.7×	130 0.7×	12	579
Britta Meier Germany	11	221 0.8×	173 0.6×	132 0.5×	109 0.5×	137 0.7×	15	543
Lene Jessen Denmark	11	343 1.2×	450 1.7×	213 0.8×	187 0.8×	52 0.3×	13	798
Cintia Folgueira Spain	15	252 0.9×	113 0.4×	179 0.7×	220 0.9×	123 0.7×	35	662
Libbey S. O′Farrell United States	10	256 0.9×	299 1.1×	252 1.0×	81 0.3×	102 0.5×	17	648
Rachel M. Mayers United Kingdom	10	154 0.5×	209 0.8×	143 0.6×	157 0.6×	39 0.2×	11	572

Countries citing papers authored by Todd M. Suter

Since Specialization

Citations

This map shows the geographic impact of Todd M. Suter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd M. Suter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd M. Suter more than expected).

Fields of papers citing papers by Todd M. Suter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd M. Suter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd M. Suter. The network helps show where Todd M. Suter may publish in the future.

Co-authorship network of co-authors of Todd M. Suter

This figure shows the co-authorship network connecting the top 25 collaborators of Todd M. Suter. A scholar is included among the top collaborators of Todd M. Suter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd M. Suter. Todd M. Suter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Nunn, Nicolas, David A. Bechtold, Todd M. Suter, et al.. (2022). The hypothalamic RFamide, QRFP, increases feeding and locomotor activity: The role of Gpr103 and orexin receptors. PLoS ONE. 17(10). e0275604–e0275604. 8 indexed citations

Willard, Francis S., Jonathan D. Douros, M Gabe, et al.. (2020). Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight. 5(17). 314 indexed citations breakdown →

Heinz, Beverly A., John M. Schaus, James P. Beck, et al.. (2016). In Vitro Characterization of a Novel Allosteric Potentiator of the Dopamine D1 Receptor. The FASEB Journal. 30(S1).

Suter, Todd M., et al.. (2010). Pharmacological characterization of the cannabinoid CB1 receptor PET ligand ortholog, [3H]MePPEP. European Journal of Pharmacology. 649(1-3). 44–50. 4 indexed citations

Takeuchi, Kumiko, Jamie H. McKinzie, Todd M. Suter, et al.. (2007). Structure–activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1. Bioorganic & Medicinal Chemistry Letters. 17(19). 5349–5352. 9 indexed citations

Takeuchi, Kumiko, Charles H. Mitch, Steven J. Quimby, et al.. (2007). Structure activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 2. Bioorganic & Medicinal Chemistry Letters. 17(24). 6841–6846. 10 indexed citations

Emmerson, Paul J., Jamie H. McKinzie, Peggy L. Surface, et al.. (2004). Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists. European Journal of Pharmacology. 494(2-3). 121–130. 29 indexed citations

Rodgers, George H., Jamie H. McKinzie, Todd M. Suter, et al.. (2003). Development of Displacement Binding and GTPγS Scintillation Proximity Assays for the Identification of Antagonists of the μ-Opioid Receptor. Assay and Drug Development Technologies. 1(5). 627–636. 9 indexed citations

Statnick, Michael A., Todd M. Suter, Susan L. Gackenheimer, et al.. (2003). Na+-dependent high affinity binding of [3H]LY515300, a 3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid receptor inverse agonist. European Journal of Pharmacology. 482(1-3). 139–150. 11 indexed citations

10.

Statnick, Michael A., Frank C. Tinsley, Brian J. Eastwood, et al.. (2003). Antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 284(6). R1399–R1408. 47 indexed citations

11.

Tschöp, Matthias H., Michael A. Statnick, Todd M. Suter, & Mark L. Heiman. (2002). GH-Releasing Peptide-2 Increases Fat Mass in Mice Lacking NPY: Indication for a Crucial Mediating Role of Hypothalamic Agouti-Related Protein. Endocrinology. 143(2). 558–568. 121 indexed citations

12.

Statnick, Michael A., Lisa S. Beavers, Helena Corominola, et al.. (2000). Decreased Expression Of apM1 in Omental and Subcutaneous Adipose Tissue of HumansWith Type 2 Diabetes. Journal of Diabetes Research. 1(2). 81–88. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact